Trial Profile
Plavix Responsiveness: Use of TNFa and genetics.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2012
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Embolism and thrombosis; Ischaemic heart disorders; Myocardial infarction
- Focus Pharmacodynamics; Pharmacogenomic
- 02 Jun 2012 New source identified and integrated (Oregon Health and Science University Institutional Review Board).
- 16 Oct 2010 New trial record